propyphenazone drug combination mecloxamine ergotamine camylofin caffeine

Also Known As:
caffeine, camylofin, ergotamine, mecloxamine, propyphenazone drug combination; Avamigran; Viatris brand of caffeine, camylofin, ergotamine, mecloxamine, propyphenazone drug combination; caffeine - camylofin - ergotamine - mecloxamine - propyphenazone
Networked: 2 relevant articles (0 outcomes, 1 trials/studies) for this Bio-Agent, Comments

Bio-Agent Context: Research Results

Related Diseases

1. Migraine Disorders (Migraine)
2. Vascular Headaches (Vascular Headache)
01/31/1966 - "[Treatment of the onset in migraine and vascular headache with Avamigran]."
Order ALL the reference details at left...

blog comments powered by Disqus
for Migraine Disorders,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 1479 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>